Coloplast Agrees to Buy Atos Medical in $2.5 Billion Deal (1)

Nov. 8, 2021, 8:15 AM UTC

Coloplast A/S agreed to buy Atos Medical to expand into care for patients who’ve had their larynx removed.

The Danish healthcare provider will acquire the company from PAI Partners, a Paris-based private equity firm, in a deal valued at 2.16 billion euros ($2.5 billion) including debt, Coloplast said in a statement Monday.

“Atos Medical represents a new long-term growth category for Coloplast operating with its own identity, brand and execution strength,” the Danish company said.

Coloplast Class B shares rose as much as 4.3% in early Copenhagen trading. The stock is up 16% this year.

Atos Medical was founded ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.